LVCLF

Living Cell Technologies Ltd.

 
Ordinary Shares International Reporting
OTCQX International OTCQX Advisor: BNY Mellon
Verified Company Profile 5/23/2017
Contact Info
  • Level 7
  • 330 Collins Street
  • GPO Box 4231
  • Melbourne, VIC 3000
  • Australia

Business Description


 
Financial Reporting/Disclosure
Reporting Status International Reporting: ASX - Australian Securities Exchange
Audited Financials Audited
Latest Report Jun 30, 2017 Quarterly Report
CIK 0001398773
Fiscal Year End 6/30
OTC Marketplace OTCQX International
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: New South Wales, Australia
Year of Inc. 2003
Employees 19 a/o Dec 18, 2016
Company Officers/Contacts
Ken M Taylor CEO
Mark Licciardo Company Secretary Manager
John Cowan Head of Finance
Kate Goland Other
Company Directors
Roy Austin Chairman
Laurie Hunter
Bernard Tuch
Robert Willcocks
Company Notes
  • Sponsored for OTCQX by BNY Mellon on 6/2/2008.
Service Providers
OTCQX Advisor
BNY Mellon
101 Barclay Street
22nd Floor
New York, NY, 10286
USA

Accounting/Auditing Firm
BDO East Coast Partnership
Level 11, 1 Margaret Street
Sydney, NSW, 2000
Australia

Legal Counsel
Not Available
Investor Relations Firm
Not Available
LVCLF Security Details Other Company Securities
Share Structure
Market Value1 $8,523,530 a/o Sep 19, 2017
Authorized Shares 496,488,328 a/o Dec 19, 2016
Outstanding Shares 74,117,653 a/o Dec 19, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
LCT - ASX - Australian Securities Exchange - Qualified
Short Selling Data
Short Interest 15,000 (200%)
Aug 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security